ICO has as of today completed the divestment of MatTek and Visikol to Sartorius, for USD 80m on a cash and debt-free basis, after customary regulatory approval has been obtained. Following transaction costs, net debt and working capital adjustments net proceeds are estimated to amount to USD 77.2m. The divestment follows the Group’s updated strategy […]
Genovis AB (publ) (“Genovis”) today announces that it has exercised its call option to acquire the remaining 75% of SEQURNA AB (“SEQURNA” or “Company”), a strategic move that accelerates Genovis’ expansion into the fast-growing genomics sector. This acquisition unlocks new product offerings for Genovis to both existing and new customers and further paves the way […]
Acquisition successfully closed for enterprise value of $5.1 billion Siemens expands AI-powered Siemens Xcelerator portfolio with end-to-end digital thread that connects data from research through to production in Life Sciences Combined capabilities expected to accelerate scientific innovation and drive long-term growth Acquisition is another milestone of Siemens’ ONE Tech Company program expanding Siemens’ offerings into the […]
The Chemistry Division of the CPH Group has entered into an agreement to purchase all substantial assets of SiliCycle Inc., a Canada-based company. The acquisition of this manufacturer of high-value chromatography gels for the pharmaceutical industries marks a further milestone in the CPH Group’s implementation of its global expansion strategy. Perlen – The CPH Group […]
Transaction Set to Close in July Synthego Solidly Positioned for Expansion & Growth Redwood City, CA — Synthego, a leading provider of CRISPR solutions, today confirmed that its sale to Perceptive Advisors, a global life sciences investor known for backing leading biotech companies, is cleared to close. This transaction, expected to close in July, will […]
Transaction Set to Close in July Synthego Solidly Positioned for Expansion & Growth Redwood City, CA — Synthego, a leading provider of CRISPR solutions, today confirmed that its sale to Perceptive Advisors, a global life sciences investor known for backing leading biotech companies, is cleared to close. This transaction, expected to close in July, will […]
In a bold move to reshape the global Laboratory Information Management System (LIMS) market, Confience has acquired Labsoft, a prominent LIMS provider in Latin America, bringing together two industry leaders with a shared vision, complementary technologies, and a relentless drive to lead. Labsoft brings several advanced product capabilities, and Confience will leverage the technology of […]
Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder Value Farmingdale, NY — Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced that on June 23, 2025, following the market close, it entered into an Agreement and Plan of Merger (the “Merger Agreement”) to be acquired […]
Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating Structure and Enables Achievement of Adjusted EBITDA Break-Even Cash & Cash Equivalents of At Least $550 Million Expected at Close […]
Combines highly complementary proteomics expertise with Illumina’s industry-leading product innovation and global market reach Positions Illumina to achieve growth in a large, expanding market Illumina and SomaLogic have partnered in proteomics co-development since late 2021 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) announced today it has entered into a definitive agreement with Standard BioTools (NASDAQ: […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
